FHL1 promoted cell cycle arrest at both G1 and G2/M in lung cancer cells, thus regulating G1 and G2/M phase-related proteins, including significant inhibition of cyclin A, cyclin B1, and cyclin D, as well as upregulation of the cyclin dependent kinase inhibitors, p21 and p2759. The gene discussed is FHL1; the disease is lung carcinoma.